Shanghai Shen Lian Biomedical Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 81.85 million compared to CNY 89.05 million a year ago. Revenue was CNY 81.85 million compared to CNY 89.05 million a year ago.

Net income was CNY 15.87 million compared to CNY 23.93 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.06 a year ago. Diluted earnings per share from continuing operations was CNY 0.04 compared to CNY 0.05 a year ago.